297 related articles for article (PubMed ID: 17064995)
21. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
22. The effect of HAART and calendar period on Kaposi's sarcoma and non-Hodgkin lymphoma: results of a match between an AIDS and cancer registry.
Pipkin S; Scheer S; Okeigwe I; Schwarcz S; Harris DH; Hessol NA
AIDS; 2011 Feb; 25(4):463-71. PubMed ID: 21139489
[TBL] [Abstract][Full Text] [Related]
23. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
[TBL] [Abstract][Full Text] [Related]
24. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 Apr; 16(4):441-51, 456, 459. PubMed ID: 12017534
[TBL] [Abstract][Full Text] [Related]
25. Hodgkin's disease in patients infected with human immunodeficiency virus: frequency, presentation and clinical outcome.
Tsimberidou AM; Sarris AH; Medeiros LJ; Mesina O; Rodriguez MA; Hagemeister FB; Romaguera J; Pro B; McLaughlin P; Dang N; Cabanillas F
Leuk Lymphoma; 2001 May; 41(5-6):535-44. PubMed ID: 11378571
[TBL] [Abstract][Full Text] [Related]
26. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
Molina A; Krishnan AY; Nademanee A; Zabner R; Sniecinski I; Zaia J; Forman SJ
Cancer; 2000 Aug; 89(3):680-9. PubMed ID: 10931469
[TBL] [Abstract][Full Text] [Related]
27. Dose-modified oral chemotherapy in the treatment of AIDS-related non-Hodgkin's lymphoma in East Africa.
Mwanda WO; Orem J; Fu P; Banura C; Kakembo J; Onyango CA; Ness A; Reynolds S; Johnson JL; Subbiah V; Bako J; Wabinga H; Abdallah FK; Meyerson HJ; Whalen CC; Lederman MM; Black J; Ayers LW; Katongole-Mbidde E; Remick SC
J Clin Oncol; 2009 Jul; 27(21):3480-8. PubMed ID: 19470940
[TBL] [Abstract][Full Text] [Related]
28. HIV-associated primary cervical non-Hodgkin's lymphoma and two other cases of primary pelvic non-Hodgkin's lymphoma.
Pham DC; Guthrie TH; Ndubisi B
Gynecol Oncol; 2003 Jul; 90(1):204-6. PubMed ID: 12821366
[TBL] [Abstract][Full Text] [Related]
29. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
[TBL] [Abstract][Full Text] [Related]
30. Non-Hodgkin's lymphoma in patients with human immunodeficiency virus infection in Taiwan.
Yang CJ; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2010 Aug; 43(4):278-84. PubMed ID: 20688287
[TBL] [Abstract][Full Text] [Related]
31. The impact of highly active antiretroviral therapy on the incidence and outcomes of AIDS-defining cancers in Southern Alberta.
Gingues S; Gill MJ
HIV Med; 2006 Sep; 7(6):369-77. PubMed ID: 16903981
[TBL] [Abstract][Full Text] [Related]
32. Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy.
Polesel J; Clifford GM; Rickenbach M; Dal Maso L; Battegay M; Bouchardy C; Furrer H; Hasse B; Levi F; Probst-Hensch NM; Schmid P; Franceschi S;
AIDS; 2008 Jan; 22(2):301-6. PubMed ID: 18097233
[TBL] [Abstract][Full Text] [Related]
33. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy.
Cheung MC; Pantanowitz L; Dezube BJ
Oncologist; 2005; 10(6):412-26. PubMed ID: 15967835
[TBL] [Abstract][Full Text] [Related]
34. Non-Hodgkin's lymphoma associated with the acquired immunodeficiency syndrome.
Cáceres W
Bol Asoc Med P R; 1995; 87(10-12):158-61. PubMed ID: 8924158
[TBL] [Abstract][Full Text] [Related]
35. Improved outcome of human immunodeficiency virus-associated plasmablastic lymphoma of the oral cavity in the era of highly active antiretroviral therapy: a report of two cases.
Lester R; Li C; Phillips P; Shenkier TN; Gascoyne RD; Galbraith PF; Vickars LM; Leitch HA
Leuk Lymphoma; 2004 Sep; 45(9):1881-5. PubMed ID: 15223650
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic approaches to AIDS-related malignancies.
Berretta M; Cinelli R; Martellotta F; Spina M; Vaccher E; Tirelli U
Oncogene; 2003 Sep; 22(42):6646-59. PubMed ID: 14528290
[TBL] [Abstract][Full Text] [Related]
37. Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma.
Sparano JA; Wiernik PH; Hu X; Sarta C; Schwartz EL; Soeiro R; Henry DH; Mason B; Ratech H; Dutcher JP
J Clin Oncol; 1996 Nov; 14(11):3026-35. PubMed ID: 8918501
[TBL] [Abstract][Full Text] [Related]
38. Clinical, virologic, and immunologic outcomes in lymphoma survivors and in cancer-free, HIV-1-infected patients: a matched cohort study.
Spagnuolo V; Travi G; Galli L; Cossarini F; Guffanti M; Gianotti N; Salpietro S; Lazzarin A; Castagna A
Cancer; 2013 Aug; 119(15):2710-9. PubMed ID: 23625649
[TBL] [Abstract][Full Text] [Related]
39. [Treatment of non-Hodgkin's lymphoma associated with acquired immnodeficiency syndrome (AIDS) at the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán].
Uriarte-Duque J; Hernández-Riverab G
Gac Med Mex; 2006; 142(2):99-102. PubMed ID: 16711542
[TBL] [Abstract][Full Text] [Related]
40. Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphoma.
Stebbing J; Gazzard B; Mandalia S; Teague A; Waterston A; Marvin V; Nelson M; Bower M
J Clin Oncol; 2004 Jun; 22(11):2177-83. PubMed ID: 15169806
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]